Correction to: Neratinib in Early-Stage Breast Cancer: A Profile of Its Use in the EU
Crossref DOI link: https://doi.org/10.1007/s40261-019-00780-x
Published Online: 2019-03-21
Published Print: 2019-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dhillon, Sohita
Text and Data Mining valid from 2019-03-21
Article History
First Online: 21 March 2019